Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma.
A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma. Cancer. 1995 Nov 01; 76(9):1629-33.
View in:
PubMed
subject areas
Adult
Aged
Carcinoma, Renal Cell
Enzyme-Linked Immunosorbent Assay
Female
Humans
Injections, Subcutaneous
Interleukin-4
Kidney Neoplasms
Male
Middle Aged
Neoplasm Metastasis
Prognosis
Receptors, IgE
Recombinant Proteins
Solubility
authors with profiles
Walter M. Stadler